Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG), covering 2019-05-28 to 2019-05-28. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines [Phase 3]